Author: WTN News

A molecular diagnostic assay that simultaneously detects and differentiates several types of influenza in a single specimen has been cleared for marketing by the Food and Drug Administration. The product, developed by the Milwaukee-based Prodesse, is the first cleared infectious disease test to detect as...

Wisconsin lost one of its most charismatic governors last week with the passing of Lee Sherman Dreyfus. In this edition of Inside Wisconsin, columnist Tom Still, who covered the Dreyfus Administration as a young reporter, remembers the former University of Wisconsin-Stevens Point chancellor, who as...

What are the real issues that all the prognosticators seem to overlook with their presidential candidate analysis and predictions? They are almost too numerous to count, especially when it comes to the future of technology and network infrastructure, says columnist James Carlini. In this edition...

Is TomoTherapy's stock suddenly dropping? Its common stock was down, temporarily at least, on the news that a competitor has received FDA clearance for a radiation therapy product to rival TomoTherapy's Hi-Art System. That competitor, Varian Medical systems, is drawing praise from market analysts who...

Diminishing oil reserves and the threat of global warming caused by releasing carbon into the atmosphere have researchers searching for a sustainable, carbon-neutral fuel to reduce our reliance on fossil fuels. UW-Madison researcher James Dumesic has created a path to such a fuel, and his...

UW-Madison's master of science in biotechnology degree responds to the realities of technology commercialization, where market potential, scientific merit, and government regulations collide. The program, which integrates content from six UW-Madison colleges, emphasizes cross-disciplinary learning in its attempt to take a comprehensive approach to business,...

Two products under development by Third Wave Technologies to test for high-risk varieties of the Human Papilloma Virus have passed another test on their way to clinical trials before the Food and Drug Administration. High-risk types of the HPV have been identified as a cause...

While the U.S. tends to think that all good technologies must come from within its borders, a recent trip to Latin America has convinced columnist Michael Rosen that America can learn from research into Brazilian and and Colombian agriculture. In this edition of Yer Biotech...